Аннотация
Bosh miya o‘smalari markaziy asab tizimining murakkab va klinik jihatdan ahamiyatli kasalliklari sirasiga kiradi. Ular neyroglial hujayralar, miya pardalari, gipofiz bezi yoki boshqa tuzilmalar asosida rivojlanadi. Birlamchi va ikkilamchi (metastatik) shakllarga bo‘linib, har bir tur klinik kechish, tashxis va davolashda o‘ziga xos xususiyatlarga ega.
Zamonaviy yondashuvlarda faqat morfologik tasnif emas, balki molekulyar markerlar ham muhim ahamiyatga ega. O‘smalar klinik jihatdan intrakranial bosim ortishi, fokal nevrologik belgilar, epileptik tutqanoqlar va kognitiv o‘zgarishlar bilan namoyon bo‘ladi. Diagnostika usullaridan magnit-rezonans tomografiya, kompyuter tomografiya va gistologik tekshiruvlar asosiy o‘rinda turadi.
Библиографические ссылки
Louis DN, Perry A, Reifenberger G, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica. 2021;142(4): 281–300.
DeAngelis LM, Mellinghoff IK. Virchow 2011 Lecture: Diagnosis and management of brain tumors. European Journal of Cancer. 2012;48(14): 2118–2126.
Бекмуродова, У. Р., Жабборов, А. А., & Султонов, Н. Н. (2022). ОСОБЕННОСТИ ТЕЧЕНИЯ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ, ПЕРЕНЕСШИХ СОVID-19. Oriental renaissance: Innovative, educational, natural and social sciences, 2(6), 270-281.
Weller M, van den Bent M, Hopkins K, et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. The Lancet Oncology. 2014;15(9): e395–e403.
Ostrom QT, Gittleman H, Truitt G, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States, 2014–2018. Neuro-Oncology. 2021;23(12 Suppl 2): iii1–iii105.
Джабборов, А. А. О. (2025, February). ОСОБЕННОСТИ ПОРАЖЕНИЯ ПЕРИФЕРИЧЕСКОЙ НЕРВНОЙ СИСТЕМЫ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ II ТИПА И АЛГОРИТМ ПРОФИЛАКТИКИ. In Scientific Conference on Multidisciplinary Studies (pp. 158-164).
Schiff D, Brown PD, Giannini C. Primary and metastatic brain tumors. Neurology in Clinical Practice. 7th Edition. Elsevier; 2022.